HK:1061 Stock Latest News
Company AnnouncementsEssex Bio-Technology Reports Profit Decline but Strong Balance Sheet in First-Half 20262M ago1061
Company AnnouncementsEssex Bio-Technology Declares Interim Dividend for First Half of 20262M ago1061
Company AnnouncementsEssex Bio-Technology Sets August Board Meeting to Review Interim Results and Dividend3M ago1061
Company AnnouncementsEssex Bio-Technology Warns of Profit Hit as China VAT Change Squeezes Margins3M ago1061
Company AnnouncementsEssex Bio-Technology’s HLX04-O Hits Phase 3 Endpoint in Wet-AMD Trial4M ago1061
Company AnnouncementsEssex Bio-Technology Shareholders Approve All AGM Resolutions and 2025 Final Dividend5M ago1061Company AnnouncementsEssex Bio-Technology Sets 2026 AGM, Proposes Dividend and Share Issue Mandate7M ago1061
Company AnnouncementsEssex Bio-Technology Delivers Higher Revenue, Profit and Dividends in 20257M ago1061
Company AnnouncementsEssex Bio-Technology Proposes Final Dividend of HKD 0.07 Per Share for 20257M ago1061
Company AnnouncementsEssex Bio-Technology Sets March Board Meeting to Approve 2025 Results and Consider Dividend7M ago1061
Company AnnouncementsEssex Bio-Technology Secures Exclusive China Distribution Rights for Osteopore Dental Implants9M ago1061
Company AnnouncementsEssex Bio-Technology Wins PRC Approval for New Sodium Hyaluronate Eye Drops9M ago1061
Company AnnouncementsEssex Bio-Technology Reports Growth in Interim 2025 Financial Results1y ago1061
Company AnnouncementsEssex Bio-Technology’s HLX04-O Application Accepted in China1y ago1061
Company AnnouncementsEssex Bio-Technology Gains Approval to Commercialize New Eye Drops in China1y ago1061
Company AnnouncementsEssex Bio-Technology Establishes New Nomination Committee1y ago1061
Company AnnouncementsEssex Bio-Technology AGM Resolutions Successfully Passed1y ago1061
Company AnnouncementsEssex Bio-Technology Announces AGM and Key Resolutions1y ago1061Company AnnouncementsEssex Bio-Technology’s Phase 3 Study for Wet-AMD Treatment Meets Primary Endpoint1y ago1061


